Di Nardo, Lucia
 Distribuzione geografica
Continente #
NA - Nord America 1.197
AS - Asia 1.061
EU - Europa 574
SA - Sud America 207
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.075
Nazione #
US - Stati Uniti d'America 1.145
SG - Singapore 479
CN - Cina 236
BR - Brasile 170
VN - Vietnam 105
IT - Italia 101
DE - Germania 95
FR - Francia 92
SE - Svezia 88
BD - Bangladesh 46
GB - Regno Unito 43
JP - Giappone 43
IN - India 39
FI - Finlandia 34
IE - Irlanda 34
ID - Indonesia 31
CA - Canada 28
HK - Hong Kong 28
RU - Federazione Russa 22
PL - Polonia 18
KR - Corea 14
ZA - Sudafrica 12
MX - Messico 11
ES - Italia 9
AR - Argentina 8
CI - Costa d'Avorio 8
BE - Belgio 6
EC - Ecuador 6
IQ - Iraq 6
NL - Olanda 6
PK - Pakistan 6
TR - Turchia 6
BO - Bolivia 5
CO - Colombia 5
KE - Kenya 5
UA - Ucraina 5
JO - Giordania 4
LT - Lituania 4
PE - Perù 4
AT - Austria 3
CL - Cile 3
CR - Costa Rica 3
HN - Honduras 3
MA - Marocco 3
VE - Venezuela 3
AL - Albania 2
AZ - Azerbaigian 2
CY - Cipro 2
MD - Moldavia 2
NI - Nicaragua 2
PT - Portogallo 2
PY - Paraguay 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BG - Bulgaria 1
BM - Bermuda 1
BS - Bahamas 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
EU - Europa 1
GM - Gambi 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
ME - Montenegro 1
MK - Macedonia 1
MY - Malesia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
RS - Serbia 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
ZM - Zambia 1
Totale 3.075
Città #
Singapore 249
San Jose 133
Chandler 132
Ashburn 111
Beijing 47
Hefei 46
The Dalles 41
Tokyo 40
Ho Chi Minh City 36
New York 36
Dallas 35
Dublin 34
Lauterbourg 34
Hanoi 27
Jakarta 27
Los Angeles 27
Rome 27
Frankfurt am Main 25
Hong Kong 25
Helsinki 23
Milan 21
Boston 18
Bremen 17
Kent 17
Munich 17
Council Bluffs 16
Santa Clara 16
Moscow 15
St Louis 15
São Paulo 15
Chicago 14
Seoul 14
Warsaw 14
Atlanta 12
Princeton 12
Tukwila 12
Boardman 11
London 11
Hyderabad 10
Redwood City 10
Düsseldorf 9
North Bergen 9
Nuremberg 9
San Mateo 9
Wilmington 9
Abidjan 8
Toronto 8
Chennai 7
Stockholm 7
Brussels 6
Buffalo 6
Lappeenranta 6
Mexico City 6
Montreal 6
Orem 6
Ottawa 6
Johannesburg 5
Paris 5
Pune 5
Rio de Janeiro 5
Turku 5
Amman 4
Amsterdam 4
Bologna 4
Boydton 4
Brooklyn 4
Cleveland 4
Da Nang 4
Denver 4
Falkenstein 4
Haiphong 4
Nairobi 4
Portsmouth 4
Roubaix 4
Ankara 3
Araraquara 3
Baghdad 3
Campinas 3
Can Tho 3
Charlotte 3
Dhaka 3
Guarulhos 3
Guayaquil 3
Hillsboro 3
Houston 3
Lima 3
Manchester 3
Marseille 3
Mumbai 3
Nova Iguaçu 3
Philadelphia 3
Phoenix 3
Poplar 3
Porto Alegre 3
Ribeirão das Neves 3
Salvador 3
Southampton 3
Taubaté 3
Ajax 2
Baku 2
Totale 1.712
Nome #
Beneficial effects of upadacitinib on alopecia areata associated with atopic dermatitis: A multicenter retrospective study 145
Spliceogenic analysis of BRCA1 c.439T>C (rs794727800) variant by High Resolution Melting Analysis 137
Therapeutic impact and management of persistent head and neck atopic dermatitis in dupilumab-treated patients 124
Dupilumab-associated ocular adverse events are predicted by low tear break-up time and correlate with high IL-33 tear concentrations in patients with atopic dermatitis 116
Molecular genetics of cutaneous squamous cell carcinoma: perspective for treatment strategies 116
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy 114
Familial Melanoma: Diagnostic and Management Implications 111
Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma 103
Histological features of immune cell infiltrate in lesional skin correlate with therapeutic response to dupilumab 102
Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective Study 101
Evaluation of the Impact of Night Shift Work on Disease Severity in Psoriatic Patients: A Case-Control Study with Clinical, Hormonal, and Immunological Evaluation 101
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy 99
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry 98
Successful response of upadacitinib in different clinical phenotypes of atopic dermatitis 97
Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis: results from an Italian multicenter study 96
Understanding the molecular genetics of basal cell carcinoma 96
Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors 95
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy 94
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy 94
Molecular alterations in basal cell carcinoma subtypes 93
Heterogeneity of BRAF, NRAS, and TERT Promoter Mutational Status in Multiple Melanomas and Association with MC1R Genotype: Findings from Molecular and Immunohistochemical Analysis 92
Low grade of satisfaction related to the use of current systemic therapies among pustular psoriasis patients: a therapeutic unmet need to be fulfilled 86
Residual disease is the main, but not the only factor impacting satisfaction in psoriatic patients undergoing biological therapies 86
Intra-patient heterogeneity of BRAF and NRAS molecular alterations in primary melanoma and metastases 85
The psychological burden during COVID-19 pandemic in a cohort of patients affected by moderate-to-severe atopic dermatitis treated with dupilumab 83
Melanoma types by in vivo reflectance confocal microscopy correlated with protein and molecular genetic alterations: A pilot study 78
Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study 73
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study 71
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series 69
Cerebrospinal fluid and serum biomarkers in idiopathic intracranial hypertension: A systematic review 65
High- and intermediate-risk susceptibility variants in melanoma families from the Mediterranean area: A multicentre cohort from the MelaNostrum Consortium 64
Clinical, dermoscopic, and confocal features of nevi and melanomas in a multiple primary melanoma patient with the MITF p.E318K homozygous mutation 55
CGRP increase in tear fluid of migraine patients is reversed by anti-CGRP monoclonal antibodies 39
Cerebrospinal fluid and serum biomarkers in idiopathic intracranial hypertension: A systematic review 34
Baricitinib for adult atopic dermatitis: real-world effectiveness, safety, and response predictors 3
Totale 3.115
Categoria #
all - tutte 14.507
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.507


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202283 1 1 1 6 7 1 1 10 3 7 21 24
2022/2023338 36 44 26 62 28 36 11 32 39 6 11 7
2023/2024261 7 46 27 34 16 28 9 8 9 6 36 35
2024/2025630 10 2 43 12 58 30 24 18 71 74 156 132
2025/20261.716 228 70 127 207 218 91 273 85 92 116 97 112
2026/202744 44 0 0 0 0 0 0 0 0 0 0 0
Totale 3.115